teva glp-1 wins US obesity approval for its generic liraglutide | News FDA Approves First Generic GLP-1

Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

Proper storage temperature is critical for maintaining GLP-1 injection stability and efficacy

Discover 7 easy GLP-1 friendly foods that help control appetite, support fat loss, balance blood sugar levels, and protect muscle masswithout overcomplicating your diet.

Louis, MO

On Tuesday, March 3, 2026, the Centers for Medicare and Medicaid Services (CMS) released Frequently Asked Questions (FAQs) (which he...

Unlike SGLT2 inhibitors (such ...